vs
Amplify Energy Corp.（AMPY）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
RIGEL PHARMACEUTICALS INC的季度营收约是Amplify Energy Corp.的1.2倍（$69.8M vs $56.6M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs 113.9%，领先270.1%），RIGEL PHARMACEUTICALS INC同比增速更快（21.2% vs -18.1%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs -13.9%）
安普利法能源公司是一家原油能源企业，总部位于美国得克萨斯州休斯顿，成立于2017年，目前在纽约证券交易所挂牌上市，核心业务围绕原油领域开展，是美国本土颇具规模的独立能源生产商。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
AMPY vs RIGL — 直观对比
营收规模更大
RIGL
是对方的1.2倍
$56.6M
营收增速更快
RIGL
高出39.3%
-18.1%
净利率更高
RIGL
高出270.1%
113.9%
两年增速更快
RIGL
近两年复合增速
-13.9%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $56.6M | $69.8M |
| 净利润 | $64.4M | $268.1M |
| 毛利率 | 93.7% | 91.5% |
| 营业利润率 | — | 33.2% |
| 净利率 | 113.9% | 384.0% |
| 营收同比 | -18.1% | 21.2% |
| 净利润同比 | 967.0% | 1769.2% |
| 每股收益（稀释后） | $1.55 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AMPYRIGL
| Q4 25 | $56.6M | $69.8M | ||
| Q3 25 | $66.4M | $69.5M | ||
| Q2 25 | $68.4M | $101.7M | ||
| Q1 25 | $72.0M | $53.3M | ||
| Q4 24 | $69.0M | $57.6M | ||
| Q3 24 | $69.9M | $55.3M | ||
| Q2 24 | $79.5M | $36.8M | ||
| Q1 24 | $76.3M | $29.5M |
净利润AMPYRIGL
| Q4 25 | $64.4M | $268.1M | ||
| Q3 25 | $-21.0M | $27.9M | ||
| Q2 25 | $6.4M | $59.6M | ||
| Q1 25 | $-5.9M | $11.4M | ||
| Q4 24 | $-7.4M | $14.3M | ||
| Q3 24 | $22.7M | $12.4M | ||
| Q2 24 | $7.1M | $-1.0M | ||
| Q1 24 | $-9.4M | $-8.2M |
毛利率AMPYRIGL
| Q4 25 | 93.7% | 91.5% | ||
| Q3 25 | 92.1% | 93.2% | ||
| Q2 25 | 93.1% | 95.6% | ||
| Q1 25 | 94.1% | 91.7% | ||
| Q4 24 | 93.5% | 89.9% | ||
| Q3 24 | 93.9% | 85.5% | ||
| Q2 24 | 93.8% | 92.4% | ||
| Q1 24 | 93.7% | 93.1% |
营业利润率AMPYRIGL
| Q4 25 | — | 33.2% | ||
| Q3 25 | -39.9% | 40.9% | ||
| Q2 25 | 18.4% | 60.1% | ||
| Q1 25 | -5.5% | 23.9% | ||
| Q4 24 | -9.6% | 28.9% | ||
| Q3 24 | 46.7% | 25.4% | ||
| Q2 24 | 17.0% | 1.2% | ||
| Q1 24 | -11.9% | -23.6% |
净利率AMPYRIGL
| Q4 25 | 113.9% | 384.0% | ||
| Q3 25 | -31.6% | 40.2% | ||
| Q2 25 | 9.3% | 58.6% | ||
| Q1 25 | -8.1% | 21.5% | ||
| Q4 24 | -10.8% | 24.9% | ||
| Q3 24 | 32.4% | 22.5% | ||
| Q2 24 | 9.0% | -2.8% | ||
| Q1 24 | -12.3% | -27.9% |
每股收益（稀释后）AMPYRIGL
| Q4 25 | $1.55 | $14.11 | ||
| Q3 25 | $-0.52 | $1.46 | ||
| Q2 25 | $0.15 | $3.28 | ||
| Q1 25 | $-0.15 | $0.63 | ||
| Q4 24 | $-0.16 | $0.82 | ||
| Q3 24 | $0.54 | $0.70 | ||
| Q2 24 | $0.17 | $-0.06 | ||
| Q1 24 | $-0.24 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $60.7M | $155.0M |
| 总债务越低越好 | — | $52.5M |
| 股东权益账面价值 | $458.7M | $391.5M |
| 总资产 | $600.9M | $513.6M |
| 负债/权益比越低杠杆越低 | — | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资AMPYRIGL
| Q4 25 | $60.7M | $155.0M | ||
| Q3 25 | — | $137.1M | ||
| Q2 25 | — | $108.4M | ||
| Q1 25 | — | $77.1M | ||
| Q4 24 | — | $77.3M | ||
| Q3 24 | — | $61.1M | ||
| Q2 24 | $502.0K | $49.1M | ||
| Q1 24 | $3.0M | $49.5M |
总债务AMPYRIGL
| Q4 25 | — | $52.5M | ||
| Q3 25 | — | $60.0M | ||
| Q2 25 | — | $60.0M | ||
| Q1 25 | — | $60.0M | ||
| Q4 24 | — | $60.0M | ||
| Q3 24 | — | $60.0M | ||
| Q2 24 | — | $60.0M | ||
| Q1 24 | — | $60.0M |
股东权益AMPYRIGL
| Q4 25 | $458.7M | $391.5M | ||
| Q3 25 | $393.0M | $117.6M | ||
| Q2 25 | $411.3M | $81.9M | ||
| Q1 25 | $402.9M | $18.6M | ||
| Q4 24 | $408.9M | $3.3M | ||
| Q3 24 | $414.7M | $-14.6M | ||
| Q2 24 | $390.3M | $-29.9M | ||
| Q1 24 | $381.0M | $-31.7M |
总资产AMPYRIGL
| Q4 25 | $600.9M | $513.6M | ||
| Q3 25 | $731.4M | $242.5M | ||
| Q2 25 | $771.3M | $206.7M | ||
| Q1 25 | $753.6M | $176.0M | ||
| Q4 24 | $747.1M | $164.0M | ||
| Q3 24 | $739.2M | $139.4M | ||
| Q2 24 | $720.4M | $128.4M | ||
| Q1 24 | $712.2M | $126.5M |
负债/权益比AMPYRIGL
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | 0.51× | ||
| Q2 25 | — | 0.73× | ||
| Q1 25 | — | 3.23× | ||
| Q4 24 | — | 18.25× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-13.4M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | -0.21× | 0.08× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流AMPYRIGL
| Q4 25 | $-13.4M | $22.0M | ||
| Q3 25 | $13.4M | $24.0M | ||
| Q2 25 | $23.7M | $30.5M | ||
| Q1 25 | $25.5M | $-893.0K | ||
| Q4 24 | $12.5M | $14.5M | ||
| Q3 24 | $15.7M | $21.7M | ||
| Q2 24 | $15.4M | $302.0K | ||
| Q1 24 | $7.7M | $-5.0M |
现金转化率AMPYRIGL
| Q4 25 | -0.21× | 0.08× | ||
| Q3 25 | — | 0.86× | ||
| Q2 25 | 3.71× | 0.51× | ||
| Q1 25 | — | -0.08× | ||
| Q4 24 | — | 1.01× | ||
| Q3 24 | 0.69× | 1.75× | ||
| Q2 24 | 2.16× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AMPY
| Oil And Gas | $54.7M | 97% |
| Other | $1.8M | 3% |
RIGL
暂无分部数据
